About AMILI
AMILI is a company based in Singapore (Singapore) founded in 2019 by David Ong, Jonathan Lee, Christopher Ting, Dennis von Berlepsch, and Jeremy Lim.. AMILI has raised $10.5 million across 2 funding rounds from investors including Emtek, G. K. Goh Holdings and Pruksa. AMILI offers products and services including Gut Health Test Kits, Probiotics, Faecal Microbiota Transplant, and AMILI Analytics. AMILI operates in a competitive market with competitors including Wacker Chemie, Enduro, BioCina, BDI biotech and Vibalogics, among others.
- Headquarter Singapore, Singapore
- Founders David Ong, Jonathan Lee, Christopher Ting, Dennis von Berlepsch, Jeremy Lim
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$1.37 M (USD)72as on Apr 30, 2024
-
Net Profit
$-3.91 M (USD)15as on Apr 30, 2024
-
EBITDA
-
Total Equity Funding
$10.5 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
Emtek
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AMILI
AMILI offers a comprehensive portfolio of products and services, including Gut Health Test Kits, Probiotics, Faecal Microbiota Transplant, and AMILI Analytics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kits for testing gut microbiome to provide personalized health insights.
Supplements designed to enhance gut microbiome balance and functionality.
Service for transplanting microbiota to treat gut health issues effectively.
Platform for analyzing gut microbiome data for industry partners.
Unlock access to complete
Unlock access to complete
Funding Insights of AMILI
AMILI has successfully raised a total of $10.5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(15 Jun 2022)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series A - AMILI | Valuation | East Ventures |
|
| Jun, 2022 | Amount | Series A - AMILI | Valuation | Vulcan Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AMILI
AMILI has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Emtek, G. K. Goh Holdings and Pruksa. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in Southeast Asian startups and publishing reports on technology and sustainability.
|
Founded Year | Domain | Location | |
|
Private equity investments are backed by a single-family office firm.
|
Founded Year | Domain | Location | |
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AMILI
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AMILI
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amili Comparisons
Competitors of AMILI
AMILI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wacker Chemie, Enduro, BioCina, BDI biotech and Vibalogics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Silicones, polymers, and bio-solutions are manufactured for various industries.
|
|
| domain | founded_year | HQ Location |
Microbial strains are manufactured by Enduro as a CDMO.
|
|
| domain | founded_year | HQ Location |
CDMO offering microbial expression systems-based biologics development and manufacturing services
|
|
| domain | founded_year | HQ Location |
Microbial strains for biopharma are developed at BDI Biotech.
|
|
| domain | founded_year | HQ Location |
CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amili
Frequently Asked Questions about AMILI
When was AMILI founded?
AMILI was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is AMILI located?
AMILI is headquartered in Singapore, Singapore.
Who is the current CEO of AMILI?
Jeremy Lim is the current CEO of AMILI. They have also founded this company.
Is AMILI a funded company?
AMILI is a funded company, having raised a total of $10.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10.5M, raised on Jun 15, 2022.
What is the annual revenue of AMILI?
Annual revenue of AMILI is $1.37M as on Apr 30, 2024.
What does AMILI do?
AMILI was founded in 2019 in Singapore and operates within the gut health sector. Data insights and analytics on microbiome abundance, functionality, and health effects are delivered through a specialized platform. Microbiome-enabled products and services are formulated for industry partners, while proprietary test kits and probiotics are made available. Therapeutics and diagnostics focused on gut health are also developed.
Who are the top competitors of AMILI?
AMILI's top competitors include Wacker Chemie, Enduro and BioCina.
What products or services does AMILI offer?
AMILI offers Gut Health Test Kits, Probiotics, Faecal Microbiota Transplant, and AMILI Analytics.
Who are AMILI's investors?
AMILI has 10 investors. Key investors include Emtek, G. K. Goh Holdings, Pruksa, East Ventures, and Vulcan Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.